12-07-2022 | Rituximab | Letter to the Editor
Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma
Published in: Annals of Hematology | Issue 10/2022
Login to get access